Survival from cancers of the kidney and ureter in england and wales up to 2001

British Journal of Cancer

Volumn 99, Issue , 2008, Pages S93-S95

  Westlake, S ^a   Cooper, N ^a   Rachet, B ^b   Coleman, M P ^b  

^a OFFICE FOR NATIONAL STATISTICS   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURVIVAL; HUMAN; HYPERTENSION; KIDNEY CANCER; KIDNEY CARCINOMA; NEPHROBLASTOMA; OBESITY; PRIORITY JOURNAL; SHORT SURVEY; SMOKING; SURVIVAL RATE; SURVIVAL TIME; UNITED KINGDOM; URETER CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; ENGLAND; FEMALE; FORECASTING; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; SOCIAL CLASS; SURVIVAL ANALYSIS; URETERAL NEOPLASMS; WALES;

EID: 52449107992     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604601     Document Type: Article

References (13)

1. Berrino F, Capocaccia R, Coleman MP, Estève J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A (eds) (2003) EUROCARE-3: the survival of cancer patients diagnosed in Europe during 1990–1994. Ann Oncol 14(Suppl 5): 1–155
2. Berrino F, Capocaccia R, Estève J, Gatta G, Hakulinen T, Micheli M, Sant M, Verdecchia A (eds) (1999) Survival of Cancer Patients in Europe: the EUROCARE-2 Study (IARC Scientific Publications No. 151). International Agency for Research on Cancer: Lyon
3. Berrino F, Estève J, Coleman MP (1995a) Basic issues in the estimation and comparison of cancer patient survival. In Survival of Cancer Patients in Europe: the EUROCARE Study. (IARC Scientific Publications No. 132), Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J (eds), pp 1–14. International Agency for Research on Cancer: Lyon
4. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J (eds) (1995b) Survival of Cancer Patients in Europe: the EUROCARE Study (IARC Scientific Publications No. 132). International Agency for Research on Cancer: Lyon
5. Brenner H, Rachet B (2004) Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 40: 2494–2501
6. Coleman MP, Babb P, Damiecki P, Grosclaude PC, Honjo S, Jones J, Knerer G, Pitard A, Quinn MJ, Sloggett A, De Stavola BL (1999) Cancer Survival Trends in england and wales 1971–1995: Deprivation and NHS Region. Studies on Medical and Population Subjects No. 61. The Stationery Office: London
7. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5 version 2.0. IARCPress: Lyon. http://www-dep.iarc.fr
8. Harris WB, Simons JW (2004) Kidney and ureter. In Clinical Oncology, Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (eds) 3rd edn, pp 2035–2058. Elsevier: Philadelphia, PA
9. Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176: 2353–2358
10. McLaughlin JK, Silverman DT, Hsing AW, Ross RK, Schoenberg JB, Yu MC, Stemhagen A, Lynch CF, Blot WJ, Fraumeni JF (1992) Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 52: 254–257
11. Mitry E, Ciccolallo L, Coleman MP, Gatta G, Pritchard-Jones K, EUROCARE Working Group (2006) Incidence of and survival from Wilms’ tumour in adults in Europe: data from the EUROCARE study. Eur J Cancer 42: 2363–2368
12. Quinn MJ, Babb P, Brock A, Kirby L, Jones J (2001) Cancer trends in england and wales 1950–1999. Studies on Medical and Population Subjects No. 66. Office for National Statistics: London
13. Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Steward J, Brenner H, Estève J, Sullivan R, Coleman MP (2008) Cancer survival in england and wales at the end of the 20th century. Br J Cancer 99(Suppl 1): S2–S10